Strategic Diagnostics is headquartered in Newark, Delaware.
Strategic Diagnostics is a healthcare services company.
Strategic Diagnostics was founded in 1990.
111 Pencader Drive,
Newark, Delaware
19702
United States,
(302) 456-6789
www.sdix.com
Strategic Diagnostics is a developer and manufacturer of immunoassay-based test kits for both field testing and laboratory use. These products are used extensively for contaminated waste site assessment and remediation, water quality management, food labeling and transgenic crop seed production.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.0/yr) | # | 3 | - | - | - | - | - | 3 |
| vol | $16M | $16M | ||||||
| 3 | ||||||||
| Financial | Deals |
|---|---|
|
BroadOak Capital Partners |
2 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
